object
analyz
clinic
characterist
patient
novel
coronaviru
pneumonia
kunm
citi
studi
correl
nutrit
statu
immun
function
method
clinic
data
patient
novel
coronaviru
pneumonia
isol
area
kunm
third
peopl
hospit
januari
februari
collect
basic
situat
clinic
characterist
laboratori
examin
ct
imag
characterist
analyz
serum
albumin
alb
prealbumin
pab
hypersensit
creactiv
protein
hscrp
cell
cell
cell
normal
control
group
analyz
simpl
linear
regress
analysi
relationship
proalbumin
cell
subpopul
count
blood
patient
patient
new
coronaviru
pneumonia
kunm
mainli
common
type
patient
first
symptom
fever
cough
total
number
white
blood
cell
peripher
blood
normal
decreas
case
lymphocyt
count
decreas
case
without
anemia
hypersensit
creactiv
protein
increas
case
procalcitonin
increas
case
albumin
decreas
case
proalbumin
decreas
case
alanin
transaminas
increas
slightli
case
alanin
transaminas
increas
slightli
case
total
bilirubin
increas
slightli
case
renal
function
blood
coagul
normal
absolut
valu
cell
decreas
case
case
case
invers
case
prealbumin
group
significantli
lower
normal
control
group
hypersensit
creactiv
protein
higher
normal
control
group
level
pab
serum
patient
linearli
correl
hscrp
cell
cell
cell
correl
coeffici
respect
show
statist
differ
conclus
clinic
characterist
novel
coronaviru
pneumonia
kunm
differ
wuhan
chang
serum
proalbumin
cell
subset
rel
obviou
chang
serum
proalbumin
may
contribut
earli
warn
novel
coronaviru
pneumonia
nutrit
statu
patient
common
mild
pneumonia
consid
decemb
new
outbreak
coronaviru
pneumonia
began
wuhan
hubei
provinc
quickli
spread
whole
countri
even
mani
oversea
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
countri
accord
outbreak
dynam
releas
china
case
come
hubei
outbreak
detect
throughout
countri
place
famou
tourism
yunnan
larg
number
import
case
incid
level
middl
whole
countri
light
type
small
number
patient
sever
critic
type
recov
rel
well
februari
death
case
clinic
work
found
signific
chang
patient
nutrit
statu
may
relat
inflamm
immun
paper
analyz
clinic
characterist
new
type
coronaviru
pneumonia
admit
third
peopl
hospit
kunm
citi
analyz
relationship
serum
proalbumin
cell
clinic
signific
studi
approv
ethic
committe
third
peopl
hospit
kunm
data
use
clinic
studi
written
consent
patient
guardian
accord
diagnosi
treatment
scheme
issu
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
nation
health
commiss
china
new
coronaviru
infect
pneumonia
diagnosi
treatment
plan
trial
diagnost
criteria
new
coronaviru
pneumonia
confirm
case
outsid
hubei
provinc
histori
epidemiolog
within
day
onset
histori
travel
live
commun
wuhan
citi
surround
area
patholog
report
area
within
day
onset
contact
histori
case
new
coronaviru
infect
posit
nucleic
acid
detect
within
day
onset
contact
patient
fever
respiratori
symptom
wuhan
surround
area
commun
case
diseas
report
aggreg
diseas
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
spss
softwar
use
data
analysi
case
rate
use
data
count
test
use
intergroup
comparison
measur
data
normal
distribut
express
measur
data
nonnorm
distribut
express
median
quartil
space
measur
data
normal
distribut
verifi
ttest
analysi
varianc
rank
sum
test
use
intergroup
comparison
nonnorm
distribut
relationship
pab
cell
subset
hscrp
analyz
regress
scatter
plot
made
simpl
linear
regress
regress
equat
calcul
p
consid
statist
signific
clinic
featur
gener
data
patient
diagnos
age
year
median
age
year
includ
children
male
femal
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
case
longterm
exposur
case
shortterm
exposur
case
unknown
exposur
time
previou
smoke
case
patient
basic
diseas
includ
patient
hypertens
patient
diabet
patient
hypothyroid
patient
hyperlipidemia
case
light
type
case
normal
type
case
critic
type
case
hubei
case
yunnan
sign
symptom
tabl
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
pulmonari
ground
glass
shadow
found
case
fig
pavement
stone
sign
case
fig
strip
shadow
case
fig
consolid
shadow
case
fig
aerat
bronchi
sign
case
fig
vascular
thicken
case
fig
typic
perform
shown
figur
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
decoct
patient
treatment
enhanc
immun
patient
use
immunoglobulin
patient
hormon
therapi
treatment
patient
hypertens
alter
calcium
antagonist
patient
treat
noninvas
ventil
assist
breath
result
show
pab
cd
cd
cd
cell
pneumonia
group
novel
coronaviru
significantli
lower
normal
control
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
group
hypersensit
creactiv
protein
higher
normal
control
group
signific
differ
albumin
normal
control
group
simpl
linear
regress
analysi
serum
pab
hscrp
cell
cell
cell
patient
novel
coronaviru
pneumonia
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
paper
first
report
clinic
studi
nonhubei
studi
china
sever
differ
compar
clinic
analysi
result
report
wuhan
jinyintan
hospit
tongji
hospit
affili
tongji
medic
colleg
huazhong
univers
scienc
technolog
refer
tongji
hospit
affili
hereaft
case
includ
studi
assess
critic
admiss
rest
case
mainli
normal
type
sever
admiss
patient
fever
cough
first
symptom
mainli
moder
low
fever
gastrointestin
symptom
studi
lymphocyt
absolut
valu
reduct
case
hypersensit
creactiv
protein
increas
significantli
lower
report
tongji
hospit
affili
less
jinyintan
hospit
report
respect
may
involv
fact
studi
mainli
base
common
type
mild
type
chang
lymphocyt
absolut
valu
hypersensit
creactiv
protein
patient
common
mild
case
new
coronaviru
pneumonia
evid
sever
critic
case
easili
ignor
clinic
observ
studi
found
decreas
prealbumin
case
previou
studi
report
prealbumin
chang
prealbumin
usual
use
clinic
evalu
nutrit
statu
bodi
halflif
serum
prealbumin
short
chang
may
occur
albumin
studi
patient
decreas
albumin
slight
decreas
patient
show
decreas
prealbumin
pulmonari
ct
find
patient
basic
consist
previou
report
twentytwo
patient
show
abnorm
find
ground
glass
densiti
shadow
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
studi
suggest
patient
novel
coronaviru
pneumonia
experi
decreas
tcell
subset
admiss
combin
clinic
type
specul
immun
function
may
suppress
impair
earli
stage
diseas
commonli
use
indic
evalu
nutrit
statu
clinic
practic
prealbumin
often
util
evalu
tumor
postop
recoveri
domest
scholar
cai
chuanqi
et
al
found
hypoalbuminemia
independ
risk
factor
sever
diseas
elderli
pneumonia
patient
studi
found
albumin
diseas
group
basic
normal
prealbumin
significantli
lower
normal
control
group
analyz
relationship
prealbumin
cell
cell
cell
respect
regress
model
show
linear
posit
correl
level
prealbumin
serum
patient
cell
cell
cell
strongest
correl
among
cell
proalbumin
acut
reactiv
protein
synthes
liver
cell
halflif
day
earli
stage
diseas
proalbumin
chang
may
caus
consumpt
proalbumin
bodi
infect
viru
lead
reduct
proalbumin
peripher
blood
recent
studi
found
inflamm
effect
inhibitor
protein
synthesi
may
also
inhibit
synthesi
viscer
prealbumin
occurr
develop
diseas
lead
low
level
prealbumin
due
fever
infect
bodi
state
high
decomposit
high
energi
demand
time
lack
energi
loss
appetit
patient
ensur
suffici
food
intak
mouth
meet
need
bodi
meanwhil
combin
basic
diseas
viscera
moder
sever
malnutrit
easili
appear
pneumonia
patient
clinic
studi
found
malnutrit
rate
patient
sever
pneumonia
high
immun
dysfunct
enter
nutrit
form
nutrit
support
usual
provid
patient
sever
pneumonia
good
nutrit
statu
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
reflect
bodi
immun
function
certain
extent
also
may
play
irreplac
role
fight
emerg
inflammatori
storm
prealbumin
use
earli
warn
indic
immun
function
patient
new
coronaviru
pneumonia
analysi
relationship
prealbumin
cell
subset
decreas
valu
prealbumin
indic
patient
cellular
immun
function
impair
play
certain
role
clinic
condit
monitor
accord
current
outbreak
report
patient
mild
normal
type
studi
conclud
lymphocyt
chang
signific
earli
stage
diseas
normal
mild
patient
chang
tcell
subset
prealbumin
might
benefici
evalu
diseas
